From adiposity to steatosis: metabolic dysfunction-associated steatotic liver disease, a hepatic expression of metabolic syndrome – current insights and future directions

From adiposity to steatosis: metabolic dysfunction-associated steatotic liver disease, a hepatic expression of metabolic syndrome – current insights and future directions

Abstract Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing health concern and the risk of its development is connected with the increasing prevalence of metabolic syndrome (MetS) which occurs as a result of some complex obesity-induced metabolic changes. It is...

Full description

Saved in:
Bibliographic Details
Main Authors: Bruno Basil, Blessing K. Myke-Mbata, Onyinye E. Eze, Augustine U. Akubue
Format: Article
Language:English
Published: BMC 2024-12-01
Series:Clinical Diabetes and Endocrinology
Subjects:
Adiposity
Metabolic syndrome
Metabolic dysfunction-associated steatotic liver disease (MASLD)
Non-alcoholic fatty liver disease (NAFLD)
Obesity
Steatosis
Online Access:https://doi.org/10.1186/s40842-024-00187-4
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s40842-024-00187-4

Similar Items